| FCVTX | VISVX | FCVTX / VISVX | |
| Total Expense Ratio | 1.45 | 0.19 | 763% |
| Annual Report Gross Expense Ratio | 1.45 | 0.19 | 763% |
| Fund Existence | 21 years | 28 years | - |
| Gain YTD | 4.840 | 6.201 | 78% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.68B | 59.8B | 8% |
| Annual Yield % from dividends | 0.66 | 1.74 | 38% |
| Returns for 1 year | -1.51 | 10.07 | -15% |
| Returns for 3 years | 3.94 | 29.38 | 13% |
| Returns for 5 years | 13.62 | 52.76 | 26% |
| Returns for 10 years | 31.51 | 160.87 | 20% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BOUT | 39.35 | 0.72 | +1.86% |
| Innovator IBD® Breakout Opps ETF | |||
| EOCT | 32.71 | 0.05 | +0.15% |
| Innovator Emerg Mkts Pwr Bffr ETF™-Oct | |||
| BSJP | 23.04 | N/A | N/A |
| Invesco BulletShares 2025 High Yield | |||
| JMST | 51.01 | -0.02 | -0.05% |
| JPMorgan Ultra-Short Municipal Inc ETF | |||
| CRCA | 2.09 | -0.37 | -15.04% |
| ProShares Ultra CRCL ETF | |||